Anastasia G. Daifotis
Publications by Year
Research Areas
Bone health and treatments, Bone health and osteoporosis research, Bone Metabolism and Diseases, Bone and Joint Diseases, Diabetes Management and Research
Most-Cited Works
- → Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis(1998)1,268 cited
- → Esophagitis Associated with the Use of Alendronate(1996)761 cited
- → Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial(2001)548 cited
- → Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial(2011)485 cited
- → Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes(2013)239 cited
- → Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development(1995)207 cited
- → Intrauterine occupancy controls expression of the parathyroid hormone-related peptide gene in preterm rat myometrium.(1990)169 cited
- → Detection Bias Due to the Effect of Finasteride on Prostate Volume: A Modeling Approach for Analysis of the Prostate Cancer Prevention Trial(2007)125 cited
- → Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus.(1992)105 cited
- → Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies(2000)105 cited